Ting Li

Title: Innovations of Ting Li in Anti-Tumor Drug Development

Introduction

Ting Li is an accomplished inventor based in Suzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-tumor drugs. His innovative work focuses on creating effective treatment options for cancer patients.

Latest Patents

Ting Li holds a patent for an "Anti-tumor platinum-based drug mineralized protein nanoparticle, preparation method therefor and use thereof." This patent describes a novel formulation that includes a platinum drug and a protein. The proteins used in this formulation are selected from albumin, transferrin, hemoglobin, and low-density lipoprotein. The platinum drugs involved in this innovation include cisplatin, iodoplatin, bromoplatin, oxaliplatin, carboplatin, or nedaplatin. The drug loading of these nanoparticles ranges from 1% to 50%, showcasing a versatile approach to drug delivery.

Career Highlights

Ting Li is affiliated with Soochow University, where he continues to advance his research in drug development. His work has garnered attention for its potential to improve cancer treatment outcomes. With a focus on innovative solutions, he is dedicated to enhancing the efficacy of anti-tumor therapies.

Collaborations

Ting Li collaborates with notable colleagues, including Huabing Chen and Yibin Deng. Their combined expertise contributes to the advancement of research in the field of oncology.

Conclusion

Ting Li's innovative contributions to anti-tumor drug development highlight his commitment to improving cancer treatment. His patented work on platinum-based drug mineralized protein nanoparticles represents a significant advancement in pharmaceutical research.